CKD

Latest Guidance Updates November 2022: updates to the sections on top takeaways for clinicians, comprehensive care, glycaemic monitoring and targets, lifestyle interventions, and glucose-lowering therapies. This update includes five updated algorithms, and new sections on sodium–glucose cotransporter-2 inhibitors and mineralocorticoid receptor antagonists. Overview This Medscape guideline summary includes actionable recommendations for the management of type 1 […]

Nancy A. Melville January 12, 2026 The US Department of Veterans Affairs (VA) and the US Department of Defense (DoD) have issued an updated clinical practice guideline on the management of chronic kidney disease (CKD), focusing on management of early-stage disease at the primary care level. The guideline addresses major recent advances in pharmacologic management, including treatment

by NYU Langone Health edited by Gaby Clark, reviewed by Robert Egan  Editors’ notes Credit: Unsplash/CC0 Public Domain Record numbers of men and women globally are now estimated to have reduced kidney function, a new study shows. Figures rose from 378 million people with the disease in 1990 to 788 million in 2023 as the world population grew

Daniela Ovadia, MD September 24, 2025   In the daily work of general practice, where every consultation must balance efficiency with accuracy, one parameter is often overlooked yet could transform cardiovascular risk management: the assessment of chronic kidney disease (CKD). At the 25th World Organisation of Family Doctors (WONCA) World Conference 2025, held recently in Lisbon, Portugal, a session

Edited by Shrabasti Bhattacharya September 03, 2025 TOPLINE: A 16-µg dose of lubiprostone, a medication used in the management of constipation, improved or preserved estimated glomerular filtration rate (eGFR) in patients with chronic kidney disease (CKD), particularly those with moderate disease. The effects likely resulted from stimulating gut bacteria to produce spermidine, which enhanced mitochondrial